Research Article
BibTex RIS Cite

Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety

Year 2024, Volume: 28 Issue: 1, 155 - 163, 28.06.2025

Abstract

Herein, we report the in vitro Acetylcholinesterase (AChE) inhibitory activities of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. The compounds were characterized by diverse spectral methods and reported by our research team previously. As a novelty we conducted in vitro AChE inhibitory activities of the title compounds and performed in silico studies to provide insight related to activity mechanism of the compounds. Compound 4f displayed the best biological activity within our compounds with 69.92% enzyme inhibition value (at a final concentration of 0.08 mg/mL) and 0.0245 mg/mL IC50 value.

References

  • [1] Moreta MPG, Burgos-Alonso N, Torrecilla M, Marco-Contelles J, Bruzos-Cidón C. Efficacy of acetylcholinesterase inhibitors on cognitive function in Alzheimer’s disease. Review of reviews. Biomedicines. 2021; 9(11): 1689. https://doi.org/10.3390/biomedicines9111689
  • [2] Marucci G, Buccioni M, Dal Ben D, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology. 2021; 190: 108352. https://doi.org/10.1016/j.neuropharm.2020.108352
  • [3] Bortolami M, Rocco D, Messore A, Di Santo R, Costi R, Madia VN, Scipione L, Pandolfi F. Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease-a patent review (2016-present). Expert Opin Therc Pat. 2021; 31(5): 399-420. https://doi.org/10.1080/13543776.2021.1874344
  • [4] Dincel ED, Hasbal-Celikok G, Yilmaz-Ozden T, Ulusoy-Güzeldemirci N. Design, biological evaluation, molecular docking study and in silico ADME prediction of novel imidazo[2,1-b]thiazole derivatives as a novel class of α-glucosidase inhibitors. J Mol Struct. 2021; 1245: 131260. https://doi.org/10.1016/j.molstruc.2021.131260
  • [5] Sun A, Chiang CP, Chiou PS, Wang JT, Liu BY, Wu YC. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus. J Oral Pathol Med. 1994; 23(4): 172-177. https://doi.org/10.1111/j.1600-0714.1994.tb01108.x
  • [6] Janssen PAJ. The Levamisole Story. Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progres des recherches pharmaceutiques. Birkhauser Basel. 1976: 347-383. https://doi.org/10.1007/978-3-0348-7094-8_11
  • [7] Dincel ED, Hasbal-Celikok G, Yilmaz-Ozden T, Ulusoy-Güzeldemirci N. Design, synthesis, biological evaluation, molecular docking, and dynamic simulation study of novel imidazo[2,1-b]thiazole derivatives as potent antioxidant agents. J Mol Struct. 2022; 1258: 132673. https://doi.org/10.1016/j.molstruc.2022.132673
  • [8] Hreenblatt HM, Kryger G, Lewis T, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 Å resolution. FEBS Lett. 1999; 463(3): 321-326. https://doi.org/10.1016/S0014-5793(99)01637-3
  • [9] Dincel ED, Gürsoy E, Yilmaz-Ozden T, Ulusoy-Güzeldemirci N. Antioxidant activity of novel imidazo[2,1-b]thiazole derivatives: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction. Bioorg Chem. 2020; 103: 104220. https://doi.org/10.1016/j.bioorg.2020.104220
  • [10] Askin S, Tahtaci H, Türkeş C, Demir Y, Ece A, Akalın Çiftçi G, Beydemir Ş. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorg Chem. 2021; 113: 105009. https://doi.org/10.1016/j.bioorg.2021.105009
  • [11] Pollastri MP. Overview on the Rule of Five. Curr Protoc Pharmacol. 2010 Jun;Chapter 9:Unit 9.12. https://doi.org/10.1002/0471141755.ph0912s49
  • [12] Robert JF, Xicluna A, Panouse JJ. Derivatives of imidazo[2,1-b]thiazole. II. Synthesis of imidazo[2,1-b]thiazole derivatives with carbonyl side chains from 2 aminothiazole. Eur J Med Chem. 1975; 10: 59-64.
  • [13] Harraga S, Nicod L, Drouhin J, Xicluna A, Panouse J, Seilles E, Rober J. Imidazo[2,1-b]thiazole derivatives. XI. Modulation of the CD-receptor of human T trypsinized lymphocytes by several imidazo[2,1-b]thiazoles. Eur J Med Chem. 1994; 29(4): 309-315. https://doi.org/10.1016/0223-5234(94)90101-5
  • [14] Ellman GL, Courtney KD, Andre Jr V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7(2): 88-95. https://doi.org/10.1016/0006-2952(61)90145-9
There are 14 citations in total.

Details

Primary Language English
Subjects Pharmaceutical Chemistry
Journal Section Articles
Authors

Efe Doğukan Dincel 0000-0002-5445-0600

Gozde Hasbal Çelikok 0000-0002-0216-7635

Tuğba Yılmaz Özden 0000-0003-4426-4502

Nuray Ulusoy Güzeldemirci 0000-0002-4495-4282

Publication Date June 28, 2025
Submission Date October 19, 2023
Acceptance Date December 4, 2023
Published in Issue Year 2024 Volume: 28 Issue: 1

Cite

APA Dincel, E. D., Hasbal Çelikok, G., Yılmaz Özden, T., Ulusoy Güzeldemirci, N. (2025). Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. Journal of Research in Pharmacy, 28(1), 155-163.
AMA Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. J. Res. Pharm. June 2025;28(1):155-163.
Chicago Dincel, Efe Doğukan, Gozde Hasbal Çelikok, Tuğba Yılmaz Özden, and Nuray Ulusoy Güzeldemirci. “Synthesis, in Vitro Acetylcholinesterase Inhibitory Activity and Molecular Modeling Studies of Imidazo[2,1-B]thiazole Derivatives Bearing Thiosemicarbazide Moiety”. Journal of Research in Pharmacy 28, no. 1 (June 2025): 155-63.
EndNote Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N (June 1, 2025) Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. Journal of Research in Pharmacy 28 1 155–163.
IEEE E. D. Dincel, G. Hasbal Çelikok, T. Yılmaz Özden, and N. Ulusoy Güzeldemirci, “Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety”, J. Res. Pharm., vol. 28, no. 1, pp. 155–163, 2025.
ISNAD Dincel, Efe Doğukan et al. “Synthesis, in Vitro Acetylcholinesterase Inhibitory Activity and Molecular Modeling Studies of Imidazo[2,1-B]thiazole Derivatives Bearing Thiosemicarbazide Moiety”. Journal of Research in Pharmacy 28/1 (June2025), 155-163.
JAMA Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. J. Res. Pharm. 2025;28:155–163.
MLA Dincel, Efe Doğukan et al. “Synthesis, in Vitro Acetylcholinesterase Inhibitory Activity and Molecular Modeling Studies of Imidazo[2,1-B]thiazole Derivatives Bearing Thiosemicarbazide Moiety”. Journal of Research in Pharmacy, vol. 28, no. 1, 2025, pp. 155-63.
Vancouver Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular modeling studies of imidazo[2,1-b]thiazole derivatives bearing thiosemicarbazide moiety. J. Res. Pharm. 2025;28(1):155-63.